The importance of functional wild‐type p53 protein is exemplified by the fact that somatic pathogenic variants in TP53 are detected in more than 50% of all cancer types, particularly more aggressive sub‐types, which constitute 28% of breast cancers 1, 2. Here, TP53 is linked to breast carcinoma.